o-Toluoyl Chloride CAS 933-88-0 Tolvaptan Intermediate Factory High Quality

Tlhaloso e Khutšoanyane:

Lebitso la lik'hemik'hale: o-Toluoyl Chloride

CAS: 933-88-0

Tekanyo: ≥99.0%

Ponahalo: Mokelikeli o Hlakileng o se Na Mobala

Bohareng ba Tolvaptan (CAS 150683-30-0) bakeng sa phekolo ea Hyponatremia

Boleng bo Phahameng, Tlhahiso ea Khoebo

Lipatlisiso: alvin@ruifuchem.com


Lintlha tsa Sehlahisoa

Lihlahisoa tse Amanang

Li-tag tsa Sehlahisoa

Tlhaloso:

Lintho tsa Lik'hemik'hale:

Lebitso la Lik'hemik'hale O-Toluoyl Chloride
Litlhaloso tse tšoanang 2-Methylbenzoyl Chloride
Nomoro ea CAS 933-88-0
Nomoro ea KAtse RF-PI396
Boemo ba Setoko Ka Setokong, Sekhahla sa Tlhahiso Ho fihlela ho Lithane
Foromo ea limolek'hule C8H7ClO
Boima ba Molek'hule 154.59
Melting Point 159.5-160.9 ℃
Ntlha e belang 88.0~90.0℃/12 mmHg (lit.)
Botenya 1.185 g/mL ho 25℃ (lit.)
Refractive Index n20 / D 1.5549 (lit.)
Ho qhibiliha ha Metsi E sebetsana le Metsi
Brand Ruifu Chemical

Litlhaloso:

Ntho Litlhaloso
Ponahalo Mokelikeli o Hlakileng o se Nang Mebala
Assay ≥99.0%
Benzoyl Chloride ≤0.30%
M&P-Methyl Benzoyl Chloride ≤0.50%
O-Toluic Acid ≤0.50%
Tšilafalo e ’ngoe e sa Boleloeng ≤0.20%
Litšila ka Kakaretso ≤1.0%
Tahlehelo ka ho Omisa ≤0.50%
Tekanyetso ea Teko Boemo ba Khoebo
Tšebeliso Mekhatlo ea Meriana

Sephutheloana le Bobolokelo:

Sephutheloana: Botlolo, 25kg/Barrel kapa 180kg Plastic drum, kapa ho latela tlhoko ea moreki.

Boemo ba polokelo:Boloka ka lijaneng tse koetsoeng sebakeng se phodileng le se omileng;Sireletsa khanya le mongobo.

Melemo:

1

LBH:

Kopo:

o-Toluoyl Chloride (CAS 933-88-0) e sebelisoa e le setsi sa meriana.o-Toluoyl Chloride e sebelisoa ho kopanngoeng ha quinolinone e le li-inhibitors tsa SARS CoV 3CLpro.E boetse e sebelisoa ha ho etsoa li-benzooxaboroles e le li-anti-inflammatory agents ka molomo.o-Toluoyl Chloride ke e bohareng ea Tolvaptan (CAS 150683-30-0) bakeng sa phekolo ea hyponatremia.Tolvaptan, eo hape e tsejoang e le OPC-41061, ke mohanyetsi ea khethang, ea nang le tlhōlisano ea arginine vasopressin receptor 2 e sebelisetsoang ho phekola hyponatremia (maemo a tlaase a sodium ea mali) a amanang le congestive heart failure, cirrhosis, le syndrome ea inappropriate antidiuretic hormone (SIADH).Otsuka Pharmaceutical e nang le laesense ea tolvaptan tlasa lebitso la khoebo la Samsca kamora hore FDA e lumelle moriana ona ka Mots'eanong 2009.

  • Ngola molaetsa wa hao mona mme o re romele wona